MURFREESBORO, TN / ACCESSWIRE / October 3, 2024 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the third quarter ended September 30, 2024. NHI plans to issue its earnings release after the market closes on Tuesday, November 5, 2024, and will host a conference call on the following day, Wednesday, November 6, 2024, at 11:00 a.m. Eastern Time to discuss the results. The number to call for this interactive teleconference is (888) 506-0062, with the access code 414723.
The live broadcast of the conference call will be available online at www.nhireit.com and at https://www.webcaster4.com/Webcast/Page/633/51151 on Wednesday, November 6, 2024, at 11:00 a.m. Eastern Time. The online replay will be available shortly after the call and remain available for one year.
About NHI
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals. For more information, visit www.nhireit.com.
Contact:
Dana Hambly, Vice President, Finance and Investor Relations
Phone: (615) 890-9100
SOURCE: National Health Investors
View the original press release on accesswire.com
KUALA LUMPUR, Malaysia, Oct. 4, 2024 /PRNewswire/ -- EBSWARE, a leading financial technology firm is…
ARLINGTON, Va., Oct. 4, 2024 /PRNewswire/ -- The Bone Health and Osteoporosis Foundation announced that it…
Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to…
The primary driver for the growth of the Disaster Recovery Software Market is the increasing…
The Dana Foundation Launches Neurotech Justice Accelerator at Mass General Brigham (NJAM) to Unite Science…
The developer of the world's first FDA-cleared, smartphone-powered kidney test is being recognized in the…